REQUEST A DEMO
Total
USD $0.00
Search more companies

Zanacea Biotec Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Zanacea Biotec Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Zanacea Biotec Private Limited is based in India, with the head office in Sikar. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on April 23, 1999. From the latest financial highlights, Zanacea Biotec Private Limited reported a net sales revenue increase of 23.6% in 2024. Its’ total assets recorded a growth of 23.19%. The net profit margin of Zanacea Biotec Private Limited increased by 1.9% in 2024.

Legal Address
Krishan Bhawan, Behind Maru Mandir, Near Ravindra Bal Niketan,
Sikar; Rajasthan; Postal Code: 332001

Contact Details: Purchase the Zanacea Biotec Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Zanacea Biotec Private Limited report to view the information.
Financial Auditors:
Purchase the Zanacea Biotec Private Limited report to view the information.
Incorporation Date:
April 23, 1999
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Zanacea Biotec Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
23.6%
Total Operating Revenue
24.84%
Operating Profit
104.3%
EBITDA
103.42%
Net Profit/Loss for the Period
124.48%
Total Assets
23.19%
Total Equity
47.88%
Operating Profit Margin
2.46%
Net Profit Margin
1.9%
Return on Equity (ROE)
11.05%
Debt / Equity
15%
Quick Ratio
3.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?